Journal of Cancer Research and Therapeutics Close
 

Figure 5: Liver IHC-P53: (a) Control untreated rats: weak cytoplasmic staining in individual hepatocyte. (b) BME-treated rats, (c) Cisplatin-treated rats, and (d) Cisplatin and BME co-treated rats: moderate cytoplasmic staining of hepatocytes with no significant difference between the three groups (×400)

Figure 5: Liver IHC-P53: (a) Control untreated rats: weak cytoplasmic staining in individual hepatocyte. (b) BME-treated rats, (c) Cisplatin-treated rats, and (d) Cisplatin and BME co-treated rats: moderate cytoplasmic staining of hepatocytes with no significant difference between the three groups (×400)